Hollencrest Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.52K Hold
50
﹤0.01% 937
2025
Q4
$4.5K Hold
50
﹤0.01% 925
2025
Q3
$4.92K Hold
50
﹤0.01% 901
2025
Q2
$4.56K Hold
50
﹤0.01% 881
2025
Q1
$5.66K Sell
50
-1
-2% -$107 ﹤0.01% 859
2024
Q4
$5.39K Hold
51
﹤0.01% 884
2024
Q3
$5.5K Buy
51
+1
+2% +$109 ﹤0.01% 844
2024
Q2
$5.43K Hold
50
﹤0.01% 826
2024
Q1
$6.6K Hold
50
﹤0.01% 768
2023
Q4
$6.08K Hold
50
﹤0.01% 785
2023
Q3
$5.61K Hold
50
﹤0.01% 795
2023
Q2
$7.28K Hold
50
﹤0.01% 799
2023
Q1
$6.46K Hold
50
﹤0.01% 809
2022
Q4
$6.38K Buy
+50
New +$5.8K ﹤0.01% 788

Other funds holding ZBH

Hollencrest Capital Management's ZBH Position: Q1 2026 in Review

Hollencrest Capital Management held its Zimmer Biomet (ZBH) position steady in Q1 2026 at 50 shares worth $4.52K. The position accounts for ﹤0.01% of the portfolio, ranked #937.

Hollencrest Capital Management first reported a position in ZBH in Q4 2022 and has held it in 14 quarters since. The position peaked at $7.28K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Hollencrest Capital Management held 50 shares of Zimmer Biomet worth $4.52K as of Q1 2026.
  • Hollencrest Capital Management left its Zimmer Biomet share count unchanged in Q1 2026.
  • Zimmer Biomet made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q1 2026, its #937 holding.
  • Hollencrest Capital Management first reported a position in Zimmer Biomet in Q4 2022 and has held it in 14 quarters since.
  • Hollencrest Capital Management's Zimmer Biomet position peaked at $7.28K in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Hollencrest Capital Management's 13F filing for Q1 2026, filed 7 May 2026.